Survival-associated meQTLs across different cancer types
We identified 23,432 meQTLs associated with patient overall survival across different cancer types at FDR < 0.05.
Cancer type
|
SNP ID
|
SNP position (hg19)
|
Alleles (A/a)
|
log-rank test p-value
|
Sample size
|
Median survival time AA
|
Median survival time Aa
|
Median survival time aa
|
|
---|---|---|---|---|---|---|---|---|---|
PCPG | rs2260117 | chr13:114154874 | C/T | 3.85E-12 | 178 | 24.23 | 29.57 | 3.32 | KM Plot |
PCPG | rs2260124 | chr13:114154730 | G/A | 3.85E-12 | 178 | 24.23 | 29.57 | 3.32 | KM Plot |
PCPG | rs2260159 | chr13:114154419 | G/A | 3.85E-12 | 178 | 24.23 | 29.57 | 3.32 | KM Plot |
PCPG | rs2260163 | chr13:114154208 | C/T | 1.21E-7 | 178 | 24.17 | 30.33 | 3.7 | KM Plot |
PCPG | rs2260165 | chr13:114153783 | T/C | 3.85E-12 | 178 | 24.23 | 29.57 | 3.32 | KM Plot |
PCPG | rs2260215 | chr13:114152928 | A/G | 4.5E-12 | 177 | 24.17 | 29.57 | 3.32 | KM Plot |
PCPG | rs2260216 | chr13:114152919 | A/G | 4.5E-12 | 177 | 24.17 | 29.57 | 3.32 | KM Plot |
PCPG | rs2260218 | chr13:114152755 | C/T | 3.6E-12 | 178 | 24.1 | 29.57 | 3.32 | KM Plot |
PCPG | rs2260250 | chr13:114172744 | C/T | 3.87E-12 | 178 | 24.17 | 29.95 | 3.32 | KM Plot |
PCPG | rs2260252 | chr13:114152517 | C/T | 4.5E-12 | 177 | 24.17 | 29.57 | 3.32 | KM Plot |
PCPG | rs2260255 | chr13:114173232 | A/G | 0.000389 | 178 | 24.1 | 29.5 | 3.7 | KM Plot |
PCPG | rs2260256 | chr13:114173236 | A/G | 0.000389 | 178 | 24.1 | 29.5 | 3.7 | KM Plot |
PCPG | rs2260289 | chr13:114151521 | G/T | 5.27E-12 | 176 | 24.23 | 29.57 | 3.32 | KM Plot |
PCPG | rs2260293 | chr13:114151360 | C/T | 5.27E-12 | 176 | 24.23 | 29.57 | 3.32 | KM Plot |
PCPG | rs2260295 | chr13:114151269 | T/C | 5.27E-12 | 176 | 24.23 | 29.57 | 3.32 | KM Plot |